Literature DB >> 31802447

Potential of Tribological Properties of Metal Nanomaterials in Biomedical Applications.

Pravin Shende1, Drashti Patel2.   

Abstract

Metallic nanomaterials show tremendous applications in biomedical devices due to compatible integration into the most of the biological systems as they are nano- structured. Metallic nanomaterials are capable of mimicking all the three major antioxidant enzymes such as catalase (CAT), peroxidase and oxidase, to control the level of reactive oxygen species (ROS) inside the cell as an alternative strategy over conventional one which has biological toxicity and have several adverse effects, if accumulation takes places during the treatment. This anti-oxidant property of metallic nanomaterials demonstrates as a promising candidate for its biomedical application in disease conditions where the excessive level of ROS causes damage to DNA, lipids and protein in several conditions such as diabetes, cancer and neurodegenerative diseases. Tribology is the study of interacting surfaces in motion and the measurement of properties such as friction, wear-tear and abrasion. While designing nano-scale biomedical devices, the consideration of tribology is particularly important because the high surface area ratio enhances problems with friction and wear-tear which can further affects its function as well as longevity.

Entities:  

Keywords:  Biomedical application; Metallic nanomaterial; Tribological testing; Tribology

Mesh:

Substances:

Year:  2020        PMID: 31802447     DOI: 10.1007/5584_2019_440

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

Review 1.  Ultrasmall-in-Nano Approach: Enabling the Translation of Metal Nanomaterials to Clinics.

Authors:  Domenico Cassano; Salvador Pocoví-Martínez; Valerio Voliani
Journal:  Bioconjug Chem       Date:  2017-12-20       Impact factor: 4.774

Review 2.  The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges.

Authors:  Anna Radomska; Jarosław Leszczyszyn; Marek W Radomski
Journal:  Adv Clin Exp Med       Date:  2016 Jan-Feb       Impact factor: 1.727

Review 3.  Nanotechnology for Alzheimer Disease.

Authors:  Jerzy Leszek; Ghulam Md Ashraf; Wai Hei Tse; Jin Zhang; Kazimierz Gasiorowski; Marco Fidel Avila-Rodriguez; Vadim V Tarasov; George E Barreto; Sergey G Klochkov; Sergey O Bachurin; Gjumrakch Aliev
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.